WO2009108364A3 - Antagonistic analogues of ghrh - Google Patents

Antagonistic analogues of ghrh Download PDF

Info

Publication number
WO2009108364A3
WO2009108364A3 PCT/US2009/001279 US2009001279W WO2009108364A3 WO 2009108364 A3 WO2009108364 A3 WO 2009108364A3 US 2009001279 W US2009001279 W US 2009001279W WO 2009108364 A3 WO2009108364 A3 WO 2009108364A3
Authority
WO
WIPO (PCT)
Prior art keywords
analogues
hghrh
inhibit
ghrh
antagonistic
Prior art date
Application number
PCT/US2009/001279
Other languages
French (fr)
Other versions
WO2009108364A2 (en
Inventor
Zheng Xin Dong
Daniel B. Deoliveira
Original Assignee
Ipsen Pharma S.A.S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipsen Pharma S.A.S. filed Critical Ipsen Pharma S.A.S.
Publication of WO2009108364A2 publication Critical patent/WO2009108364A2/en
Publication of WO2009108364A3 publication Critical patent/WO2009108364A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

There is provided a novel series of synthetic antagonistic analogues of hGHRH(l- 29)NH2 (SEQ E) NO: 1). These analogues inhibit the activity of endogenous hGHRH on the pituitary GHRH receptors, and therefore prevent the release of growth hormone. The analogues also inhibit the proliferation of human cancers through a direct effect on the cancer cells. The inhibitory potencies of the new analogues result from replacement of various amino acids.
PCT/US2009/001279 2008-02-27 2009-02-27 Antagonistic analogues of ghrh WO2009108364A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US6731808P 2008-02-27 2008-02-27
US61/067,318 2008-02-27
US20736609P 2009-02-11 2009-02-11
US61/207,366 2009-02-11

Publications (2)

Publication Number Publication Date
WO2009108364A2 WO2009108364A2 (en) 2009-09-03
WO2009108364A3 true WO2009108364A3 (en) 2010-01-07

Family

ID=41016657

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/001279 WO2009108364A2 (en) 2008-02-27 2009-02-27 Antagonistic analogues of ghrh

Country Status (1)

Country Link
WO (1) WO2009108364A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111533800B (en) * 2020-03-18 2021-08-31 浙江湖州纳福生物医药有限公司 Novel somatotropin-releasing hormone analogous peptide modification and dimerization preparation and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689318A (en) * 1985-08-29 1987-08-25 The Salk Institute For Biological Studies GRF analogs
US20050148515A1 (en) * 2002-08-09 2005-07-07 Dong Zheng X. Growth hormone releasing peptides
US20070042950A1 (en) * 2003-08-05 2007-02-22 Administrators Of The Tulane Educational Fund, The Antagonistic analogs of gh rh (2003)

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689318A (en) * 1985-08-29 1987-08-25 The Salk Institute For Biological Studies GRF analogs
US20050148515A1 (en) * 2002-08-09 2005-07-07 Dong Zheng X. Growth hormone releasing peptides
US20070042950A1 (en) * 2003-08-05 2007-02-22 Administrators Of The Tulane Educational Fund, The Antagonistic analogs of gh rh (2003)

Also Published As

Publication number Publication date
WO2009108364A2 (en) 2009-09-03

Similar Documents

Publication Publication Date Title
WO2006005140A3 (en) Proteinaceous compounds and uses therefor
WO2005016953A3 (en) Antagonistic analogs of gh-rh (2003)
LT2570414T (en) Heterocyclic aromatic compounds useful as growth hormone secretagogues
GB0713652D0 (en) Formulations of human growth hormone comprising a non-naturally encoded amino acid
EP2594582A3 (en) Peptide vaccines with Seq Id No: 110, 111, 387, 112, 394 114, 116, 117 or 121 for cancers expressing tumor-associated antigens
GT201200236A (en) AGONIST POLYPEPTIDES THAT LINK TO DR5
WO2006113452A3 (en) Glycoprotein hormone analogs
HK1138011A1 (en) Template-fixed peptidomimetics
WO2009120831A3 (en) Novel n-and c-terminal substituted -antagonistic analogs of human gh-rh
WO2005074626A3 (en) Compositions, methods and uses for a novel family of peptides
WO2004066966A3 (en) Peptide yy analogs
WO2009048752A3 (en) Insecticidal substituted azinyl derivatives
WO2005066207A8 (en) Glucagon-like peptide-1 analogs with long duration of action
AU2003290059A1 (en) Use of cd137 antagonists for the treatment of tumors
WO2009108364A3 (en) Antagonistic analogues of ghrh
NZ603611A (en) Insulin-like growth factor 1 receptor binding peptides
MXPA05013465A (en) Cis-imidazolines as mdm2 inhibitors.
NZ592670A (en) Corticotrophin releasing hormone receptor 2 peptide agonists and uses thereof
WO2006113828A3 (en) Use of biocompatible in-situ matrices for delivery of therapeutic cells to the heart
TW200505497A (en) Stabilized, solid-state polypeptide particles
WO2003087069A3 (en) Dipeptidic growth hormone secretagogues
EP3983002A4 (en) Therapeutic pegylated growth hormone antagonists
WO2011014680A3 (en) Gastric inhibitory peptide variants and their uses
WO2005105832A3 (en) Biologically active peptide vapeehptllteaplnpk derivatives
MY148135A (en) Platelet aggregation inhibitor composition

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09714255

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 09714255

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE